Green Cross Health Limited (NZE:GXH)
New Zealand · Delayed Price · Currency is NZD 1.930
+0.010 (0.52%)
Aug 21, 2026, 4:43 PM NZST
Green Cross Health Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 545.98 | 523.76 | 503.92 | 493.61 | 478.09 | |
Revenue Growth | 4.24% | 3.94% | 2.09% | 3.25% | -16.18% |
Cost of Revenue | 479.41 | 464.14 | 447.76 | 435.4 | 407.23 |
Gross Profit | 66.57 | 59.62 | 56.16 | 58.21 | 70.86 |
Selling, General & Admin | 2.9 | 3.13 | 4.32 | 3 | 0.39 |
Operating Expenses | 23.45 | 22.48 | 24.84 | 25.08 | 23.37 |
Operating Income | 43.12 | 37.14 | 31.31 | 33.13 | 47.49 |
Interest Expense | -9.83 | -10.48 | -10.27 | -7.8 | -6.18 |
Interest & Investment Income | 0.39 | 0.59 | 0.9 | 0.58 | 0.08 |
Earnings From Equity Investments | 2.15 | 1.59 | 1.2 | 1.32 | 1.89 |
EBT Excluding Unusual Items | 35.82 | 28.84 | 23.14 | 27.23 | 43.28 |
Asset Writedown | - | -0.01 | -0.72 | -0.13 | -0.84 |
Pretax Income | 35.82 | 28.84 | 22.42 | 27.1 | 42.44 |
Income Tax Expense | 9.92 | 8.09 | 6.59 | 6.8 | 13.02 |
Earnings From Continuing Operations | 25.9 | 20.74 | 15.83 | 20.3 | 29.42 |
Earnings From Discontinued Operations | - | - | -0.28 | 30.25 | 3.68 |
Net Income to Company | 25.9 | 20.74 | 15.55 | 50.55 | 33.09 |
Minority Interest in Earnings | -5.5 | -4.77 | -3.8 | -5.32 | -9.19 |
Net Income | 20.4 | 15.98 | 11.76 | 45.23 | 23.9 |
Net Income to Common | 20.4 | 15.98 | 11.76 | 45.23 | 23.9 |
Net Income Growth | 27.67% | 35.88% | -74.01% | 89.25% | 42.68% |
Shares Outstanding (Basic) | 144 | 144 | 143 | 143 | 143 |
Shares Outstanding (Diluted) | 144 | 144 | 144 | 144 | 144 |
Shares Change | 0.12% | 0.10% | -0.04% | 0.11% | 0.24% |
EPS (Basic) | 0.14 | 0.11 | 0.08 | 0.32 | 0.17 |
EPS (Diluted) | 0.14 | 0.11 | 0.08 | 0.31 | 0.17 |
EPS Growth | 27.57% | 35.73% | -74.00% | 89.07% | 42.33% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 45.01 | 46.8 | 38.56 | 40.2 | 61.74 |
Free Cash Flow Per Share | 0.31 | 0.33 | 0.27 | 0.28 | 0.43 |
Dividend Per Share | 0.085 | 0.052 | 0.045 | 0.070 | 0.065 |
Dividend Growth | 61.91% | 16.67% | -35.71% | 7.69% | - |
Gross Margin | 12.19% | 11.38% | 11.14% | 11.79% | 14.82% |
Operating Margin | 7.90% | 7.09% | 6.21% | 6.71% | 9.93% |
Profit Margin | 3.74% | 3.05% | 2.33% | 9.16% | 5.00% |
Free Cash Flow Margin | 8.24% | 8.94% | 7.65% | 8.14% | 12.91% |
EBITDA | 48.28 | 41.91 | 37.57 | 39.43 | 53.68 |
EBITDA Margin | 8.84% | 8.00% | 7.46% | 7.99% | 11.23% |
D&A For EBITDA | 5.16 | 4.77 | 6.25 | 6.3 | 6.18 |
EBIT | 43.12 | 37.14 | 31.31 | 33.13 | 47.49 |
EBIT Margin | 7.90% | 7.09% | 6.21% | 6.71% | 9.93% |
Effective Tax Rate | 27.70% | 28.07% | 29.40% | 25.11% | 30.68% |